Welcome to
Brookstreet is a global, award-winning PEVC investor. Our 2.0 Thesis is built on optimising the Efficiency Frontier through Diversification across Stages, Markets, Regions, and Instruments. We invest in Artificial Intelligence (AI) innovations that deliver transformative commercial solutions in Digital Transformation, Green Transition, Longevity, and Dual-Use Defence Technologies. Headquartered in London’s Mayfair, we operate worldwide, partnering with founders and investors across the USA, Europe, MENA, and Asia.
Swissmed Health
“We are thrilled to partner with Gottfried and Omiros of Brookstreet. This investment will enable us to take our patient care and experience to the next level.”
— George Xydas, CEO, Swissmed Health